Thabor Therapeutics’s website
1 known investors
Thabor Therapeutics is an INSERM spin-off developing a first-in-class therapeutic antibody that targets extracellular AGR2 to treat inflammatory mucosal diseases. Its non-immunosuppressive approach aims to restore epithelial homeostasis by preventing inflammation, fibrosis, and loss of epithelial integrity.
Investors · 1
Frequently asked questions
- What does Thabor Therapeutics’s website do?
- Thabor Therapeutics is an INSERM spin-off developing a first-in-class therapeutic antibody that targets extracellular AGR2 to treat inflammatory mucosal diseases. Its non-immunosuppressive approach aims to restore epithelial homeostasis by preventing inflammation, fibrosis, and loss of epithelial integrity.
- Who are Thabor Therapeutics’s website's investors?
- Thabor Therapeutics’s website's investors include AdBio partners.